Previous 10 | Next 10 |
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, has announced that the U.S. Food and Drug Administration (FDA) has accepted ...
Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, today announced it will present at the Jefferies Virtual Hea...
Legend Biotech ([[LEGN]] +4.9%) is on the rise after announcing that the European Medicines Agency ((EMA)) has accepted the marketing application for ciltacabtagene autoleucel (cilta-cel) for relapsed and/or refractory multiple myeloma ((RRMM)).In December, Legend announced the beginning of r...
These Biotech Stocks Are Trending In The Stock Market Now As an investor in the stock market , biotech stocks have always been an intriguing sector to invest in. Companies in this industry are usually less affected by global events and economic uncertainties. This is because, re...
“We are bullish on the cell and gene therapy space,” noted BTIG analyst Justin Zelin highlighting the importance of stock picking in the area given “the limited targets and indications to market.”In the area of cell therapy, Zelin initiates the coverage on six comp...
Legend Biotech (LEGN): Q1 GAAP EPS of -$0.30 beats by $0.05.Revenue of $13.68M (+18.4% Y/Y)Press Release For further details see: Legend Biotech EPS beats by $0.05
Rolling submission of BLA to the FDA completed for ciltacabtagene autoleucel (cilta-cel) for the treatment of relapsed or refractory multiple myeloma (RRMM) European Marketing Authorisation Application (MAA) submitted for cilta-cel for the treatment of RRMM New and updated cil...
The following slide deck was published by Legend Biotech Corporation in conjunction with this event. For further details see: Legend Biotech (LEGN) Investor Presentation - Slideshow
Fisker FSR +15% after announcing an agreement with Foxconn to produce a new vehicle.Net Element (NETE) +15%.Hallmark Financial Services HALL +14% on Q1 results.LifeMD LFMD +15% on Q1 results.Aeva Technologies AEVA +14% on Q1 results.Elys Game ...
Longer term follow-up data from the pivotal CARTITUDE-1 study of cilta-cel in heavily pretreated patients with relapsed or refractory multiple myeloma The first presentation of data from the CARTITUDE-2 study of cilta-cel in earlier lines of multiple myeloma treatment ...
News, Short Squeeze, Breakout and More Instantly...
Legend Biotech Corporation Company Name:
LEGN Stock Symbol:
NASDAQ Market:
Legend Biotech Corporation Website:
SOMERSET, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Friday, August 9, 2024, to review second-quarter 2024 results. During the webcast and confe...
SOMERSET, N.J., July 02, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today positive overall survival results from CARTITUDE-4, an ongoing, global randomized, open-label Phase 3 study evaluating the efficacy and sa...
2024-06-20 17:01:11 ET USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 20,2024 – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number o...